MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction]

Abstract

Wang S, Du S, Lv Y, Zhang F, Wang W. Cancer Management and Research. 2019;11:3111–3123 The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over alleged image duplication in Figures 4D and 8B with similar images from unrelated articles, specifically: Figure 4D, panel WERI-RB-1 si-HMGB1 appears to have been duplicated with a similar image in Figure 2C from Cheng et al, 2020 (https://doi.org/10.2147/OTT.S218876). Figure 8B, panels miR-NC; miR-665 mimics, far left and miR-NC; miR-665 mimics, centre-right appear to have been duplicated with similar images in Figure 8A from Dou et al, 2020 (https://doi.org/10.3389/fphar.2019.01700) and Figure 7B from Jiao et al, 2019 (https://doi.org/10.2147/OTT.S210567), respectively. The authors did not respond to our queries and the Editor determined the findings of the study were no longer valid and advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper